
NeoGenomics Laboratories specializes in comprehensive cancer genetics testing and information services, offering advanced diagnostics to pharmaceutical clients for clinical trials. Headquartered in Fort Myers, FL, the company operates multiple CAP accredited and CLIA certified laboratories across the United States and Europe, focusing on cytogenetics, flow cytometry, FISH, molecular genetics, immunohistochemistry, and next-gen sequencing (NGS). NeoGenomics is committed to connecting patients with life-altering therapies while adhering to data protection laws and investing in secure technologies.
NeoGenomics is seeking a Director of Digital Pathology to lead the organization’s Digital Pathology strategy, focusing on whole slide imaging, telepathology, and integrating emerging technologies like generative AI. The role involves fostering innovation, driving operational excellence, and collaborating with multiple teams to advance digital transformation and modernizing diagnostic systems. This is a remote position with a Monday – Friday day shift and a start date early 2026.
NeoGenomics Laboratories specializes in comprehensive cancer genetics testing and information services, offering advanced diagnostics to pharmaceutical clients for clinical trials. Headquartered in Fort Myers, FL, the company operates multiple CAP accredited and CLIA certified laboratories across the United States and Europe, focusing on cytogenetics, flow cytometry, FISH, molecular genetics, immunohistochemistry, and next-gen sequencing (NGS). NeoGenomics is committed to connecting patients with life-altering therapies while adhering to data protection laws and investing in secure technologies.